Penumbra, Inc. (NYSE:PEN) Shares Acquired by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Penumbra, Inc. (NYSE:PEN) by 4.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,251 shares of the company’s stock after purchasing an additional 136 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Penumbra were worth $869,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. raised its position in Penumbra by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 271,574 shares of the company’s stock valued at $64,493,000 after purchasing an additional 3,807 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in shares of Penumbra during the fourth quarter worth $3,553,000. HighTower Advisors LLC boosted its position in shares of Penumbra by 3.2% during the 4th quarter. HighTower Advisors LLC now owns 5,980 shares of the company’s stock worth $1,420,000 after acquiring an additional 188 shares in the last quarter. Atria Investments Inc purchased a new position in Penumbra in the fourth quarter valued at approximately $221,000. Finally, Envestnet Portfolio Solutions Inc. raised its holdings in Penumbra by 3.7% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 2,867 shares of the company’s stock worth $681,000 after purchasing an additional 101 shares in the last quarter. 88.88% of the stock is owned by hedge funds and other institutional investors.

Penumbra Price Performance

PEN stock opened at $249.53 on Thursday. The company has a quick ratio of 3.68, a current ratio of 6.30 and a debt-to-equity ratio of 0.02. The stock’s 50 day moving average is $271.10 and its two-hundred day moving average is $268.01. The company has a market capitalization of $9.66 billion, a PE ratio of 235.41, a P/E/G ratio of 2.23 and a beta of 0.47. Penumbra, Inc. has a 52-week low of $148.00 and a 52-week high of $310.00.

Penumbra (NYSE:PEN) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $0.83 EPS for the quarter, topping analysts’ consensus estimates of $0.66 by $0.17. The firm had revenue of $324.14 million during the quarter, compared to the consensus estimate of $315.72 million. Penumbra had a net margin of 3.41% and a return on equity of 11.14%. The firm’s revenue was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.41 earnings per share. Analysts predict that Penumbra, Inc. will post 3.67 earnings per share for the current fiscal year.

Analyst Ratings Changes

PEN has been the topic of several research analyst reports. Royal Bank Of Canada lifted their price target on Penumbra from $315.00 to $330.00 and gave the stock an “outperform” rating in a research report on Thursday, April 24th. Stifel Nicolaus set a $318.00 target price on shares of Penumbra and gave the company a “buy” rating in a report on Thursday, April 24th. UBS Group restated a “buy” rating and issued a $330.00 price target (up previously from $320.00) on shares of Penumbra in a research report on Thursday, April 24th. Robert W. Baird lifted their price objective on shares of Penumbra from $316.00 to $325.00 and gave the company an “outperform” rating in a research report on Thursday, April 24th. Finally, Wall Street Zen raised shares of Penumbra from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 14th. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Penumbra currently has an average rating of “Moderate Buy” and a consensus price target of $302.40.

Insider Activity

In other Penumbra news, EVP Johanna Roberts sold 900 shares of Penumbra stock in a transaction on Monday, May 12th. The stock was sold at an average price of $298.55, for a total transaction of $268,695.00. Following the sale, the executive vice president owned 65,314 shares of the company’s stock, valued at $19,499,494.70. The trade was a 1.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Arani Bose sold 12,000 shares of Penumbra stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $298.73, for a total transaction of $3,584,760.00. Following the sale, the director owned 302,819 shares in the company, valued at approximately $90,461,119.87. This represents a 3.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 114,210 shares of company stock valued at $31,582,595. Company insiders own 4.20% of the company’s stock.

Penumbra Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.